DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Corcept Therapeutics
Corcept Therapeutics
UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C
Untitled
CORCEPT THERAPEUTICS INCORPORATED (Exact Name of Corporation As Specified in Its Charter)
PRESCRIBING INFORMATION KORLYM® (Mifepristone) 300 Mg Tablets These Highlights Do Not Include All the Information Needed to Use KORLYM® Safely and Effectively
Corcept Therapeutics Announces Third Quarter 2020 Financial Results and Provides Corporate Update
Efficacy and Safety of the Selective Glucocorticoid Receptor Modulator
A Validated Predictive Algorithm of Post-Traumatic Stress Course Following Emergency Department Admission After a Traumatic Stressor
Andrew E. Greenstein1; Pamela N. Munster2; Jasgit C. Sachdev3; Gini
2014-15 Catalog
CORCEPT THERAPEUTICS INCORPORATED (Exact Name of Corporation As Specified in Its Charter)
CORCEPT THERAPEUTICS INCORPORATED (Exact Name of Corporation As Specified in Its Charter)
Corcept Therapeutics Announces Poster Presentations On
CORCEPT THERAPEUTICS INCORPORATED (Exact Name of Corporation As Specified in Its Charter)
Drug Companies & Doctors
CORCEPT THERAPEUTICS INCORPORATED (Exact Name of Registrant As Specified in Its Charter)
Corcept Therapeutics Settles Patent Litigation with Sun Pharmaceutical
United States Securities and Exchange Commission Form
Rebecca Ray, FNP-C2 1Diabetes and Endocrine Associates, Privia Medical Group, Alexandria, VA; 2Corcept Therapeutics, Menlo Park, CA
Top View
Corcept Therapeutics Incorporated (Exact Name of Registrant As Specified in Its Charter)
Corcept Therapeutics Incorporated (Exact Name of Registrant As Specified in Its Charter)
UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C
Relacorilant with Nab-Paclitaxel
SPARK Enrollment Form
Interview with Barney Carroll
Commercial/Healthcare Exchange PA Criteria Effective: April 27,2020
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update
Q2 2017,ERX.SPA.15 Mifepristone (Korlym)
Financial Crisis Report Written and Edited by David M
Medication Guide KORLYM® (KOR-Lim) (Mifepristone) Tablets
CORCEPT THERAPEUTICS INCORPORATED (Exact Name of Corporation As Specified in Its Charter)
Korlym Drug Monograph
Is Mifepristone Useful in Psychotic Depression?
CORCEPT THERAPEUTICS INCORPORATED (Exact Name of Corporation As Specified in Its Charter)
KORLYM® Safely and Effectively
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2018 Audited Financial Results and Provides Update
Clinical Management of Patients with Cushing Syndrome Treated with Mifepristone: Consensus Recommendations David R
United States Securities and Exchange Commission Form
Specific Antipsychotic Drugs Prescribed for Dementia Could Increase Mortality
Is There an (Unbiased) Doctor in the House? Journalists Often Forget That Conflicts of Interest Might Bias the Opinions of Their Expert Sources
Common Stock
Reversal of Antipsychotic-Induced Weight Gain in Rats with Miricorilant, a Selective Glucocorticoid Receptor (GR) Modulator Ada P
Corcept Therapeutics Incorporated (Exact Name of Registrant As Specified in Its Charter)
KORLYM (Mifepristone) RATIONALE for INCLUSION in PA PROGRAM
Corcept Therapeutics Announces First Patient Dosed in Phase 3 Trial of Relacorilant to Treat Patients with Cushing’S Syndrome
2013-14 Catalog
Corcept Therapeutics to Present Data at the American Society of Clinical Oncology Annual Meeting
Korlym™ (Mifepristone) Prior Authorization with Quantity Limit
Preliminary Results from RELIANT Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer